Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,405,260
-$230,006 QoQ
Shares Held
58,358
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,120
of 2,821 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HighPoint Advisor Group LLC holds $31,885,552 across 11 Drug Manufacturers - General names. PFE ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
38,942 | $9,799,364 | |
| 2 | JNJ |
Johnson & Johnson
|
27,404 | $6,959,793 | |
| 3 | LLY |
ELI LILLY & Co
|
5,555 | $6,662,834 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,349 | $2,743,346 | |
| 5 | PFE |
Pfizer Inc
This page
|
58,358 | $1,405,260 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,738 | $1,103,958 | |
| 7 | AMGN |
Amgen Inc
|
2,946 | $1,066,805 | |
| 8 | NVS |
Novartis AG
|
5,024 | $787,361 |
All Filings in PFE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,405,260 | 58,358 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,635,266 | 58,236 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,447,586 | 58,136 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $4,320,516 | 169,565 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,735,305 | 236,605 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,812,159 | 229,367 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $5,368,106 | 202,341 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,168,850 | 213,160 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $7,481 | 238,337 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,438,667 | 195,988 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,389,516 | 187,201 | Shares | Sole | 2024-03-26 | |
| 2022-06-30 | $6,491,305 | 123,809 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $5,941,573 | 138,144 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,733,465 | 120,875 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,446,270 | 95,122 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $3,278,629 | 89,069 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,555,381 | 69,629 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $2,213,988 | 67,706 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,360,456 | 72,318 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||